ImageneBio, Inc. (IMA)

Every figure this model derived for IMA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-12-31
cash 136,153,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 141,112,000 AssetsCurrent 2026-06-30
current liabilities 6,573,000 LiabilitiesCurrent 2026-06-30
equity 142,074,000 StockholdersEquity 2026-06-30
interest expense 489,000 InterestExpenseOperating 2025-12-31
ocf -52,586,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 800,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 17,121,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IMA on one particular measure came for.

RatioValue
current ratio21.47
current ratio reported21.47
deferred revenue growth-94.56
growth cv82.97
interest cover-120.57
roic-786.68

What to be careful about

What this model itself distrusts about IMA's figures. Written by the derivation as it ran, not added afterwards.